Ticlopidine Hydrochloride



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 30.6%
Antiplatelet Therapy 11.3%
Hypertension 6.5%
Myocardial Infarction 6.5%
Carotid Artery Stenosis 4.8%
Drug Use For Unknown Indication 4.8%
Coronary Angioplasty 3.2%
Myocardial Ischaemia 3.2%
Prophylaxis 3.2%
Pyrexia 3.2%
Spinal Anaesthesia 3.2%
Stent Placement 3.2%
Thrombosis Prophylaxis 3.2%
Transient Ischaemic Attack 3.2%
Angioplasty 1.6%
Anticoagulant Therapy 1.6%
Bipolar Disorder 1.6%
Cerebral Infarction 1.6%
Cerebrovascular Accident 1.6%
Colitis Ulcerative 1.6%
Diarrhoea 8.0%
Normochromic Normocytic Anaemia 8.0%
Post Procedural Haemorrhage 8.0%
Thrombotic Microangiopathy 8.0%
Thrombotic Thrombocytopenic Purpura 8.0%
Aspergillosis 4.0%
Bronchial Haemorrhage 4.0%
Cerebral Haemorrhage 4.0%
Cholestasis 4.0%
Diarrhoea Haemorrhagic 4.0%
Drug Rash With Eosinophilia And Systemic Symptoms 4.0%
Gastrointestinal Tract Adenoma 4.0%
Haematemesis 4.0%
Hemiparesis 4.0%
Hepatitis Cholestatic 4.0%
Hypertensive Crisis 4.0%
Leukopenia 4.0%
Lupus-like Syndrome 4.0%
Myalgia 4.0%
Neuroborreliosis 4.0%
Secondary
Drug Use For Unknown Indication 28.2%
Acute Myocardial Infarction 10.0%
Cerebral Infarction 9.3%
Antiplatelet Therapy 7.7%
Hypertension 6.2%
Myocardial Infarction 3.9%
Dementia Alzheimer's Type 3.5%
Cerebrovascular Accident 3.1%
Wound Infection 3.1%
Anticoagulant Therapy 2.7%
Diabetes Mellitus 2.7%
Gastritis 2.7%
Arteriosclerosis Obliterans 2.3%
Coronary Artery Bypass 2.3%
Prophylaxis 2.3%
Thrombosis Prophylaxis 2.3%
Angina Pectoris 1.9%
Dialysis 1.9%
Hyperlipidaemia 1.9%
Inflammation 1.9%
Toxic Epidermal Necrolysis 10.0%
Cardiac Tamponade 6.0%
Interstitial Lung Disease 6.0%
Liver Disorder 6.0%
Mediastinal Haematoma 6.0%
Rhabdomyolysis 6.0%
Stevens-johnson Syndrome 6.0%
Supraventricular Extrasystoles 6.0%
Tracheal Stenosis 6.0%
Cholestatic Liver Injury 4.0%
Colitis Collagenous 4.0%
Fall 4.0%
Gastrointestinal Necrosis 4.0%
Leukocytoclastic Vasculitis 4.0%
Liver Injury 4.0%
Sepsis 4.0%
Serotonin Syndrome 4.0%
Shock Haemorrhagic 4.0%
Thrombotic Thrombocytopenic Purpura 4.0%
Aplasia Pure Red Cell 2.0%
Concomitant
Product Used For Unknown Indication 18.1%
Hypertension 16.6%
Drug Use For Unknown Indication 13.4%
Rheumatoid Arthritis 9.2%
Diabetes Mellitus 6.6%
Thrombosis Prophylaxis 3.4%
Cerebral Infarction 3.3%
Constipation 2.8%
Insomnia 2.5%
Osteoporosis 2.5%
Hypercholesterolaemia 2.4%
Myocardial Infarction 2.4%
Depression 2.3%
Hyperparathyroidism Secondary 2.3%
Angina Pectoris 2.2%
Myocardial Ischaemia 2.2%
Anaemia 2.0%
Coronary Artery Disease 2.0%
Gastritis 1.8%
Cardiac Failure 1.7%
Pyrexia 8.2%
Vomiting 8.2%
Ileus Paralytic 7.3%
Osteonecrosis 6.4%
Paralysis 6.4%
Chronic Obstructive Pulmonary Disease 5.5%
Malaise 5.5%
Myocardial Infarction 5.5%
Somnolence 5.5%
Syncope 5.5%
Ventricular Tachycardia 5.5%
Skin Ulcer 4.5%
Constipation 3.6%
Prostate Cancer 3.6%
Rhabdomyolysis 3.6%
Septic Shock 3.6%
Wheezing 3.6%
Anaemia 2.7%
Atrial Flutter 2.7%
Convulsion 2.7%
Interacting
Essential Thrombocythaemia 75.0%
Thrombocytosis 25.0%
Drug Interaction 100.0%